Nexstim Receives Two NBS System Orders from Hospitals in Europe
Press release, Helsinki, 4 October 2021 at 10 AM(EEST)
Nexstim Receives Two NBS System Orders from Hospitals in Europe
Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it has received a new NBS System order and a NBS System upgrade order from European hospitals.
The NBS system order is from a new customer and the upgrade order was made by an existing customer for Nexstim. These new NBS5 platform deliveries to the hospitals enable neurosurgical diagnostics as well as MDD and pain therapy with the Nexstim system.
Nexstim’s NBS System with SmartFocus® nTMS is highly differentiated from other currently available TMS products due to its unique and highly sophisticated 3D navigation that uses its proprietary E-field algorithm to visualize the exact location, orientation, and magnitude of the stimulation.
Mikko Karvinen, CEO of Nexstim says: "Happy to announce these sales to our European customers.It is important for us to both maintain existing customer relationships and to expand our customer base, and we are looking forward to seeing these hospitals in action with our systems. We are glad to see continued interest to our diagnostic and therapy systemplatform in Europe.”
Further information is available on the website www.nexstim.com, or by contacting:
Mikko Karvinen, CEO
+358 50 326 4101
mikko.karvinen@nexstim.com
About Nexstim Plc
Nexstim is a Finnish, globally operating medical technology company. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders.
Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.
SmartFocus® technology is used in Nexstim’s proprietary Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT® system is CE marked for the treatment of major depression and chronic neuropathic pain.
In addition, Nexstim is commercializing its SmartFocus® based Navigated Brain Stimulation (NBS) system for diagnostic applications. The NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain. Nexstim shares are listed on the Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden.
For more information please visit www.nexstim.com
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Chris Hackney joins Meltwater as Chief Product Officer18.4.2024 19:13:51 CEST | Press release
SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- Meltwater, a leading global provider of social, media and consumer intelligence, today announces the appointment of Chris Hackney as Chief Product Officer. In this pivotal role, Chris will lead Meltwater’s product organization and spearhead the strategic direction, expansion, and operation of the company’s product portfolio, with the needs of Meltwater’s customers at the heart of this strategy. Hackney joins Meltwater with over 25 years in technology and a proven track record of driving innovation and growth for B2B SaaS companies, developing and executing product strategies and managing cross-functional teams. Throughout his career, Hackney has built and exited several pioneering companies at the leading edge of emerging fields; the first of which was Virtue, an early pioneer in social SaaS, which was acquired by Oracle. His time leading Oracle’s Customer Success organization was followed by subsequent executive positions at Trendkite,
Regulatoriskt pressmeddelande 2024–04–1818.4.2024 19:09:17 CEST | Press release
Den 18:e april 2024 hölls årsstämma i Virtune AB (publ) och nedan följer en sammanfattning av de beslut som fattades: Stämman beslutade att fastställa den i årsredovisningen intagna resultaträkningen och balansräkningen avseende räkenskapsåret 1 januari - 31 december 2023.Stämman beslutade att disponera resultatet i enlighet med styrelsens i förvaltningsberättelsen intagna förslag.Styrelseledamöterna och VD beviljades ansvarsfrihet avseende räkenskapsåret 1 januari - 31 december 2023.Beslutades, i enlighet med styrelsens förslag, om att inget arvode ska utgå till styrelseledamöterna.Beslutades, i enlighet med styrelsens förslag, att konsultarvode får utgå till styrelsen för ej sedvanligt styrelsearbete, vilket även ska redovisas för vid nästa stämma.Beslutades att arvode ska utgå till revisor enligt godkänd räkning.Beslutades om omval av styrelseledamoten Christopher Kock och nyval av Erik Fischbeck, Laurent Kssis & Fredrik Djavidi. Erik Fischbeck valdes till ordförande.Beslutades att
Annual General Meeting 2024: Tecan shareholders endorse all motions proposed by the Board of Directors18.4.2024 17:46:00 CEST | Press release
Annual General Meeting 2024: Tecan shareholders endorse all motions proposed by the Board of Directors Increase in the dividend from CHF 2.90 to CHF 3.00 per share Monica Manotas elected as additional independent member of the Board of DirectorsLukas Braunschweiler, Myra Eskes, Oliver Fetzer, Matthias Gillner, Karen Huebscher, Christa Kreuzburg and Daniel R. Marshak re-elected as members of the Board of DirectorsLukas Braunschweiler confirmed by shareholders as Chair of the BoardMyra Eskes, Oliver Fetzer, Christa Kreuzburg and Daniel R. Marshak confirmed as members of the Compensation CommitteeVarious amendments to the Articles of Incorporation approvedAll proposals relating to compensation approvedApproval of the Report on Non-Financial Matters 2023 (Sustainability Report) Männedorf, Switzerland, April 18, 2024 – The Annual General Meeting of the Tecan Group (SIX Swiss Exchange: TECN) endorsed all motions proposed by the Board of Directors. Shareholders approved the Annual Report, the
Ipsos: Continued momentum in Q118.4.2024 17:45:30 CEST | Press release
Continued momentum in Q1 Total growth: 4.8% Organic growth: 4.5% Paris, 18 April 2024 – Ipsos, one of the world’s leading market research companies, achieves a solid first quarter, with a revenue of €557.5m. Revenue (€m)20242023202220212020Q1557.5532.0547.8466.3428.7Q2555.1 574.0527.0357.3Q3588.0 601.5526.3468.6Q4714.7 682.1627.1582.9Total2,389.82,405.32,146.71,837.4 This income level confirms the continuation of the Group’s sustained growth. First-quarter growth stands at 4.8%, including 4.5% organic growth, 2.7% scope effect, and -2.4% of adverse currency effects. Ben Page, CEO of Ipsos, states: “The start of the year is encouraging. It demonstrates our ability to deliver sustainable solid growth combined with a high level of operating margin. Our geographical and sectoral diversity, which provides greater resilience, combined with the talent of our 20,000 employees, are major advantages for continuing our development. In a geopolitical environment that remains uncertain, we confirm
Q1 2024 Trading Statement18.4.2024 17:40:47 CEST | Press release
COMPANY ANNOUNCEMENT NO 12/2024 - April 18, 2024 Strong business momentum continued into 2024 – organic EBIT growth guidance raised Statement by Royal Unibrew’s CEO, Lars Jensen: “The first quarter has marked a strong start to the year. The business momentum we built throughout 2023 has continued into 2024. The continued strong performance of our markets in Northern Europe, combined with a normalized Italian On-Trade beer channel and a strong rebound in our International segment, drove solid organic volume growth of 6% in the first quarter. Strong value management efforts from our organization across all categories ensured organic net revenue growth of 10% in the first quarter. Going into 2024, we further intensified our focus on delivering the efficiency improvements after some turbulent years with unprecedented high inflation, strong volume growth and a series of acquisitions. This increased focus starts to yield results towards the end of the first quarter. Vrumona has now begun pro